Established in 1939, Yaopharma has a long history. Yaopharma has the fast growth after joining Fosun Group in 2002, started to explore the international markets, focus on API export and improve technology innovation. Now, it’s the largest supplier of Clindamycin HCl API to US market.

Yaopharma annually budgets 5%-10% of its annual sales to R&D, focusing on products for liver protection, anti-infection, cardiovascular, nutrition and nervous system. In recent years, Yaopharma keeps a 30% annual increase in its sales revenue. Its main products, Atuomolan, Yanhuning and Cefametazone, take more than 50% of the market share.

Now, Yaopharma has grown into a modern and high-tech pharmaceutical company integrating R&D, manufacturing and marketing & sales function, with 5 subsidiaries including Chongqing Carelife Pharmaceutical Co., Ltd. Carelife is an export-oriented API manufacturer dedicated to the development of the global markets with long term efforts. More than 80% of its APIs are exported to US and Europe. Now, it’s the largest API supplier for Clindamycin HCl to US market. Currently, Carelife has 6 APIs which have regulatory approvals from US FDA, EU EDQM, Japan PMDA, German health authority and India Ministry of Health.